Current ATM View - Proc-9175501
National Canola Pathology Program – epidemiology, surveillance and management strategies
Show close time for other time zones
The Australian canola industry has produced on average 3.5 million tonnes annually over the past 5 years, with exports alone resulting in $1.6 billion annually. In addition to direct profits from canola production, canola is an essential part of the cropping system, providing significant and reliable yield benefits through the control of diseases and weeds for subsequent cereal crops. The projection for the Australian canola industry is to produce 6.1 million tonnes per year by 2025 (Australian Oilseeds Federation). Some of the main limitations to this expansion and threats to the canola industry are from diseases, especially those caused by fungi. Without the continual control of diseases such as blackleg and sclerotinia stem rot, the canola industry cannot be sustainable or profitable. Furthermore, with the continual expansion of the canola industry the impact of these diseases will only increase due to the intensification of rotations and greater amounts of disease inoculum. The total estimated area planted with canola in 2016 was 615,661 hectares (Northern region), 654,023 hectares (Southern region) and 2,541,302 hectares (Western region) with an average of at least 50% of this being impacted by diseases particularly in the medium-high rainfall zones. The price per tonne in 2016/2017 was $520 and the yield was estimated at 1.4 tonnes per hectare averaged across all regions. With 15% diseases impact, the cost to the industry was over $200M. The aim of this research is to further develop the existing national canola pathology program to maintain the profitability of the canola industry. The project will monitor all diseases of canola and provide information to farmers regarding management of these diseases and risk of yield loss ensuring enduring profitability to the Australian canola growers.
Tenderers must familiarise themselves with further information found at https://grdc.com.au/research/applying-and-reporting/current-procurement National Canola Pathology Program including terms and conditions of participation, required forms of response and draft contract
1) The Applicant must be a single legal entity or recognised firm of partners.
2) The Applicant must be financially viable. For the purposes of this condition, “financially viable” means that the Tenderer has not had any of the following events occur in respect of it:
a) a meeting of creditors being called or held within the past five years;
b) the appointment of a liquidator, provisional liquidator or administrator within the past five years;
c) the appointment of a controller (as defined in section 9 of the Corporations Act (2001)), or analogous person appointed, including in respect of any of its property within the past five years;
d) a failure to comply with a statutory demand in respect of the payment of any debt;
e) an inability to pay debts as they fall due or otherwise becoming insolvent;
f) becoming incapable of managing its own affairs for any reason;
g) taking any step resulting in insolvency under administration (as defined in section 9 of the Corporations Act 2001);
h) entering into a compromise or arrangement with, or assignment for the benefit of, any of its creditors, or any analogous event.
3) The Applicant and any proposed subcontractor must be compliant with the Workplace Gender Equality Act 2012.
4) The Applicant must include in its application details of any known circumstances that may give rise to an actual or potential Conflict of Interest with GRDC in responding to this procurement. The Applicant's response will be taken into account in the evaluation.
Grains Investment Portal: https://access.grdc.com.au